6801 - 6810 of 9131 Results
Title
Year
-
OPENTitle: Binding to serine 65‐phosphorylated ubiquitin primes Parkin for optimal PINK 1‐dependent phosphorylation and activationJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 8Start Page: 939End Page: 954Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.15252/embr.201540352Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201540352Citation Count: 252
-
OPENTitle: Variations in Cardiovascular Structure, Function, and Geometry in Midlife Associated With a History of Hypertensive PregnancyJournal Name: HypertensionPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 75Issue #: 6Start Page: 1542End Page: 1550Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1161/hypertensionaha.119.14530Best OA location URL: https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.119.14530Citation Count: 65
-
OPENTitle: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 8Start Page: 3518End Page: 3524Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01897Citation Count: 101
- Contingent negative variation: a biomarker of abnormal attention in functional movement disorders2020OPENTitle: Contingent negative variation: a biomarker of abnormal attention in functional movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 6Start Page: 985End Page: 994Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/ene.14189Best OA location URL: https://escholarship.org/uc/item/4kw389mzCitation Count: 24
-
OPENTitle: Revised criteria for the diagnosis and staging of Alzheimer’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 8Start Page: 2121End Page: 2124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7Best OA location URL: https://www.nature.com/articles/s41591-024-02988-7.pdfCitation Count: 180
-
OPENTitle: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseasesJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 31Issue #: 8Start Page: 2567End Page: 2577Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-025-03833-1Best OA location URL: https://www.nature.com/articles/s41591-025-03833-1.pdfCitation Count: 26
-
OPENTitle: Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 15253End Page: 15253Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-72190-5Best OA location URL: https://www.nature.com/articles/s41598-020-72190-5.pdfCitation Count: 24
-
OPENTitle: Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedoniaJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 10Start Page: 863End Page: 870Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2022-330790Best OA location URL: https://jnnp.bmj.com/content/jnnp/early/2023/05/25/jnnp-2022-330790.full.pdfCitation Count: 25
-
OPENTitle: Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 23Start Page: 6139End Page: 6146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddu334Best OA location URL: http://doi.org/10.1093/hmg/ddu334Citation Count: 241
-
OPENTitle: Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-onesJournal Name: European Journal of Medicinal ChemistryPublisher: Elsevier BVVol: 70Issue #:Start Page: 758End Page: 767Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.ejmech.2013.10.052Best OA location URL: https://doi.org/10.1016/j.ejmech.2013.10.052Citation Count: 48